These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6992934)

  • 1. Insulin-induced lipoatrophy: evidence for an immune pathogenesis.
    Reeves WG; Allen BR; Tattersall RB
    Br Med J; 1980 Jun; 280(6230):1500-3. PubMed ID: 6992934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin-related complications of insulin therapy: epidemiology and emerging management strategies.
    Richardson T; Kerr D
    Am J Clin Dermatol; 2003; 4(10):661-7. PubMed ID: 14507228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insulin lipoatrophy and its elimination through the use of monocomponent insulin].
    Maaz E
    Z Gesamte Inn Med; 1976 Nov; 31(22):941-5. PubMed ID: 1035452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-induced Lipoatrophy in a Patient on Insulin Analogue Therapy: a Case Report.
    Yanachkova V; Staynova R
    Folia Med (Plovdiv); 2020 Sep; 62(3):597-600. PubMed ID: 33009748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoatrophy secondary to human insulin treatment. Immunological study.
    Igea JM; Escalada J; Cuevas M; Sainz T; Barrio R
    Allergol Immunopathol (Madr); 1992; 20(4):173-5. PubMed ID: 1485599
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature.
    Holstein A; Stege H; Kovacs P
    Expert Opin Drug Saf; 2010 Mar; 9(2):225-31. PubMed ID: 20001763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoatrophy with insulin analogues in type I diabetes.
    Babiker A; Datta V
    Arch Dis Child; 2011 Jan; 96(1):101-2. PubMed ID: 20570843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of insulin lipoatrophy by dexamethasone injection.
    Whitley TH; Lawrence PA; Smith CL
    JAMA; 1976 Feb; 235(8):839-40. PubMed ID: 946314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin-induced lipoatrophy--caused by monocomponent insulin?].
    Gyimesi A; Iványi J
    Orv Hetil; 1989 Dec; 130(51):2751-2. PubMed ID: 2689957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoatrophy induced by recombinant human insulin injection.
    Murao S; Hirata K; Ishida T; Takahara J
    Intern Med; 1998 Dec; 37(12):1031-3. PubMed ID: 9932635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human insulin analog--induced lipoatrophy.
    Lopez X; Castells M; Ricker A; Velazquez EF; Mun E; Goldfine AB
    Diabetes Care; 2008 Mar; 31(3):442-4. PubMed ID: 18162498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoatrophy associated with rapid-acting insulin analogues in young patients with type 1 diabetes mellitus.
    Szypowska A; Skórka A; Pańkowska E
    Pediatr Endocrinol Diabetes Metab; 2008; 14(2):117-8. PubMed ID: 18721499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin allergy and extensive lipoatrophy in child with type 1 diabetes.
    Beltrand J; Guilmin-Crepon S; Castanet M; Peuchmaur M; Czernichow P; Levy-Marchal C
    Horm Res; 2006; 65(5):253-60. PubMed ID: 16582568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of insulin lipoatrophy with monocomponent insulin.
    Teuscher A
    Diabetologia; 1974 Jun; 10(3):211-4. PubMed ID: 4845721
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipohypertrophy and lipoatrophy complicating treatment with highly purified bovine and porcine insulins.
    McNally PG; Jowett NI; Kurinczuk JJ; Peck RW; Hearnshaw JR
    Postgrad Med J; 1988 Nov; 64(757):850-3. PubMed ID: 3076667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipoatrophy after insulin injections can be treated with lipofilling].
    Lund PS; Sjøstrand H; Matzen SH
    Ugeskr Laeger; 2016 Dec; 178(49):. PubMed ID: 27959262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs.
    Radermecker RP; Piérard GE; Scheen AJ
    Am J Clin Dermatol; 2007; 8(1):21-8. PubMed ID: 17298103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of lipoatrophy with insulin detemir.
    Del Olmo MI; Campos V; Abellán P; Merino-Torres JF; Piñón F
    Diabetes Res Clin Pract; 2008 Apr; 80(1):e20-1. PubMed ID: 18281121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papular polymorphous light eruption. Fibrin, complement, and immunoglobulin deposition.
    Muhlbauer JE; Mihm MC; Harrist TJ
    Arch Dermatol; 1984 Jul; 120(7):866-8. PubMed ID: 6375577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled and blinded study of immunoreactant deposition at the dermal-epidermal junction of patients with primary fibrositis syndrome.
    Caro XJ; Wolfe F; Johnston WH; Smith AL
    J Rheumatol; 1986 Dec; 13(6):1086-92. PubMed ID: 3550073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.